Trends and Predictors of Premature Termination of Cardiovascular Trials
Open Access
- 16 March 2026
- journal article
- Published by Elsevier in JACC: Advances
- Vol. 5 (4) , 102606
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Participation of Women in Cardiovascular Trials From 2017 to 2023JAMA Network Open, 2025
- Patient Enrollment for Cardiovascular Clinical Trials in the United StatesJAMA Cardiology, 2025
- Enrollment of Females in Randomized Trials for Glucagon-Like Peptide 1 Receptor AgonistsJACC: Advances, 2024
- Influences on clinical trial participation: Enhancing recruitment through a gender lens - A scoping reviewContemporary Clinical Trials Communications, 2024
- One-Year Follow-Up of Vascular Intervention Trials Disrupted by the COVID-19 Pandemic: A Use-Case landscapeCardiovascular Revascularization Medicine, 2022
- Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A reviewContemporary Clinical Trials Communications, 2018
- Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: Insights from the ClinicalTrials.gov registryAmerican Heart Journal, 2014
- Prevalence, Characteristics, and Publication of Discontinued Randomized TrialsJAMA, 2014
- Overcoming the challenges of conducting research with people who have advanced heart failure and palliative care needsEuropean Journal of Cardiovascular Nursing, 2012
- Representation of the Elderly, Women, and Minorities in Heart Failure Clinical TrialsArchives of internal medicine (1960), 2002